Literature DB >> 16060139

Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium.

Lourdes Peña de la Vega1, Fernando C Fervenza, Donna Lager, Thomas Habermann, Nelson Leung.   

Abstract

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world and is characterized by a progressive accumulation of functionally incompetent monoclonal lymphocytes. Renal involvement has been described in CLL but is uncommon. Granulomatous interstitial nephritis is a rare but characteristic hallmark of certain diseases such as sarcoidosis and tuberculosis. These epithelial reactions have also been reported with medications, infections, inflammation, Wegener's granulomatosis, and jejunoileal bypass. We present a 74-year-old woman with a stage 0 chronic lymphocytic leukemia who developed acute renal failure following the initiation of alendronate. The renal biopsy revealed an acute granulomatous interstitial nephritis. Infectious and inflammatory etiologies were ruled out. Hemodialysis was required despite discontinuation of all medications. Partial recovery of renal function occurred after 6 weeks of prednisone therapy and cyclophosphamide. This report describes a unique case of acute granulomatous interstitial nephritis and leukemic cell kidney infiltration by CLL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16060139     DOI: 10.1081/jdi-65397

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  3 in total

Review 1.  Bone health issues in sarcoidosis.

Authors:  Nadera J Sweiss; Elyse E Lower; Peter Korsten; Timothy B Niewold; Murray J Favus; Robert P Baughman
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

2.  Granulomatous tubulointerstitial nephritis secondary to omeprazole.

Authors:  Quaid Nadri; Mohammed Mahdi Althaf
Journal:  BMJ Case Rep       Date:  2014-10-16

3.  Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.

Authors:  Danielle E Robinson; M Sanni Ali; Victoria Y Strauss; Leena Elhussein; Bo Abrahamsen; Nigel K Arden; Yoav Ben-Shlomo; Fergus Caskey; Cyrus Cooper; Daniel Dedman; Antonella Delmestri; Andrew Judge; Muhammad Kassim Javaid; Daniel Prieto-Alhambra
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.